Ranbaxy Laboratories Ltd (RANB.NS)
1 Apr 2015
MUMBAI - The BSE Sensex and Nifty rose on Wednesday, posting their first weekly gain in four and the biggest since Jan. 23 week, as lenders rallied ahead of the Reserve Bank of India's policy review, while Sun Pharmaceutical Industries and Ranbaxy Laboratories surged ahead of a planned merger.
MUMBAI, April 1 - Indian shares rose on Wednesday, posting their first weekly gain in four and the biggest since Jan. 23 week, as banks rallied ahead of the central bank's policy review, while Sun Pharmaceutical Industries and Ranbaxy Laboratories surged ahead of a planned merger.
MUMBAI, April 1 - Indian shares rose on Wednesday, on track to snap a three-week losing streak, led by gains in pharmaceutical stocks such as Sun Pharmaceutical Industries and Ranbaxy Laboratories ahead of the latter's amalgamation with the former.
** Ranbaxy Laboratories Ltd rises as much as 5.1 pct to hit an all-time high
MUMBAI - India's largest drugmaker Sun Pharmaceutical Industries Ltd will look at making more large acquisitions even as it winds up a $3.2 billion deal to buy smaller rival Ranbaxy Laboratories Ltd.
* To boost annual R&D spending to about $300 mln (Adds managing director comments)
MUMBAI, March 25 - Indian shares edged down on Wednesday to their near six-week lows and were heading for a sixth straight session of falls, as caution ahead of the expiry of monthly derivatives and the end of the fiscal year hit blue-chips such as Larsen & Toubro.
MUMBAI, March 25 - Sun Pharmaceutical Industries Ltd, India's largest drugmaker by sales, said on Wednesday its $3.2 billion acquisition of smaller rival Ranbaxy Laboratories Ltd will not restrict it from making further large acquisitions.
** Pharmaceutical stocks, traditionally seen as defensives, gain on churning ahead of the U.S. Federal Reserve policy meeting outcome on Wednesday
MUMBAI - A U.S. federal judge has denied Indian generic drugmaker Ranbaxy Laboratories Ltd's bid to reinstate approvals granted to it to launch the first copies of the heartburn drug Nexium and the antiviral Valcyte, a court document showed.